BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falkenback D, Öberg S, Johnsson F, Johansson J. Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up. Scandinavian Journal of Gastroenterology 2009;44:1277-87. [DOI: 10.3109/00365520903314157] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilder-Smith CH, Materna A, Martig L, Lussi A. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol 2017;17:113. [PMID: 29070010 DOI: 10.1186/s12876-017-0670-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
2 Bresadola V, Adani GL, Londero F, Leo CA, Cherchi V, Lorenzin D, Rossetto A, Vit G, Baccarani U, Terrosu G, Anna DD. Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern. World J Gastrointest Pathophysiol 2011; 2(3): 42-48 [PMID: 21860835 DOI: 10.4291/wjgp.v2.i3.42] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Shah A, Shibli F, Kitayama Y, Fass R. The Natural Course of Gastroesophageal Reflux Disease: A Critical Appraisal of the Literature. J Clin Gastroenterol 2021;55:12-20. [PMID: 32909972 DOI: 10.1097/MCG.0000000000001419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Worrell SG, Demeester TR. Role of LES Augmentation for Early Progressive Disease in GERD and Fundoplication for End-Stage Disease in GERD. In: Vaezi MF, editor. Diagnosis and Treatment of Gastroesophageal Reflux Disease. Cham: Springer International Publishing; 2016. pp. 145-60. [DOI: 10.1007/978-3-319-19524-7_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Ronkainen J, Talley NJ, Storskrubb T, Johansson SE, Lind T, Vieth M, Agréus L, Aro P. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52. [PMID: 21946284 DOI: 10.1038/ajg.2011.326] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
6 Huynh P, Konda V, Sanguansataya S, Ward MA, Leeds SG. Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication. Surg Laparosc Endosc Percutan Tech 2020;31:264-76. [PMID: 33347088 DOI: 10.1097/SLE.0000000000000888] [Reference Citation Analysis]
7 Savarino E, de Bortoli N, De Cassan C, Della Coletta M, Bartolo O, Furnari M, Ottonello A, Marabotto E, Bodini G, Savarino V. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esophagus. 2017;30:1-9. [PMID: 27862680 DOI: 10.1111/dote.12511] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
8 Malfertheiner P, Nocon M, Vieth M, Stolte M, Jaspersen D, Koelz HR, Labenz J, Leodolter A, Lind T, Richter K. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care-the ProGERD study. Aliment Pharmacol Ther. 2012;35:154-164. [PMID: 22070159 DOI: 10.1111/j.1365-2036.2011.04901.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 60] [Article Influence: 9.5] [Reference Citation Analysis]
9 Braxton DR, Nickleach DC, Liu Y, Farris AB 3rd. Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus. Virchows Arch 2014;465:135-43. [PMID: 24863247 DOI: 10.1007/s00428-014-1590-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
10 Bonavina L, Fisichella PM, Gavini S, Lee YY, Tatum RP. Clinical course of gastroesophageal reflux disease and impact of treatment in symptomatic young patients. Ann N Y Acad Sci 2020;1481:117-26. [PMID: 32266986 DOI: 10.1111/nyas.14350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Manabe N, Haruma K. Optimal acid suppressive treatment for adequate symptom relief and prevention of the complications of gastroesophageal reflux disease: differences in long-term clinical course and pathophysiology among disease subtypes. Esophagus 2017;14:113-21. [DOI: 10.1007/s10388-016-0558-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Loffeld SM, Dackus GM, Loffeld RJ. The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints: . European Journal of Gastroenterology & Hepatology 2011;23:1122-6. [DOI: 10.1097/meg.0b013e32834b8d18] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Labenz J, Chandrasoma PT, Knapp LJ, DeMeester TR. Proposed approach to the challenging management of progressive gastroesophageal reflux disease. World J Gastrointest Endosc 2018; 10(9): 175-183 [PMID: 30283600 DOI: 10.4253/wjge.v10.i9.175] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
14 Worrell SG, Greene CL, DeMeester TR. The state of surgical treatment of gastroesophageal reflux disease after five decades. J Am Coll Surg. 2014;219:819-830. [PMID: 25241236 DOI: 10.1016/j.jamcollsurg.2014.05.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Yu Y, Ding X, Wang Q, Xie L, Hu W, Chen K. Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux Disease. Gastroenterology Res 2011;4:70-5. [PMID: 27942317 DOI: 10.4021/gr284w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
16 Hvid-jensen F, Pedersen L, Munk EM, Drewes AM, Funch-jensen P. Long-term complications to reflux disease in community practice. A 17-year cohort study of 4706 patients. Scandinavian Journal of Gastroenterology 2011;46:1179-86. [DOI: 10.3109/00365521.2011.594084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
17 DeMeester SR. Laparoscopic Hernia Repair and Fundoplication for Gastroesophageal Reflux Disease. Gastrointest Endosc Clin N Am 2020;30:309-24. [PMID: 32146948 DOI: 10.1016/j.giec.2019.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Bruley des Varannes S, Coron E, Galmiche JP. Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs? Best Pract Res Clin Gastroenterol. 2010;24:905-921. [PMID: 21126703 DOI: 10.1016/j.bpg.2010.09.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
19 Fuchs KH, DeMeester TR, Otte F, Broderick RC, Breithaupt W, Varga G, Musial F. Severity of GERD and disease progression. Dis Esophagus 2021:doab006. [PMID: 33575739 DOI: 10.1093/dote/doab006] [Reference Citation Analysis]
20 Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 2013;27:325-37. [PMID: 23998972 DOI: 10.1016/j.bpg.2013.06.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]